Apatinib beyond first progression is associated with prolonged overall survival in patients with advanced breast cancer: Results from an observational study-Reference-Cited by-同舟云学术

Apatinib beyond first progression is associated with prolonged overall survival in patients with advanced breast cancer: Results from an observational study

Published:2024-03-14 Issue:5 Volume:27 Page:
ISSN:1792-0981
Container-title:Experimental and Therapeutic Medicine
language:
Short-container-title:Exp Ther Med

Author:

Wang Jing¹,Jia Jinghao²,Liu Jingjing³,Yao Xuemin²,Yuan Zhiyong¹

Affiliation:

1. Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Tianjin 300060, P.R. China

2. Department of Chemoradiotherapy, North China University of Science and Technology Affiliated Hospital, Tangshan, Hebei 063000, P.R. China

3. Department of Chemoradiotherapy, Tangshan People's Hospital, Tangshan, Hebei 063000, P.R. China

Publisher

Spandidos Publications

Reference39 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

2. Angiogenesis and metabolism: Entwined for therapy resistance;Jiménez-Valerio;Trends Cancer,2017

3. Blood vessels and peripheral nerves as key players in cancer progression and therapy resistance;Roda;Cancers (Basel),2021

4. Development of in vitro and in vivo tools to evaluate the antiangiogenic potential of melatonin to neutralize the angiogenic effects of VEGF and breast cancer cells: CAM assay and 3D endothelial cell spheroids;Laborda-Illanes;Biomed Pharmacother,2023

5. Overexpression of vascular endothelial growth factor 189 in breast cancer cells leads to delayed tumor uptake with dilated intratumoral vessels;Hervé;Am J Pathol,2008